These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36459712)

  • 1. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
    Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
    Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
    Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
    Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
    Verma M; Gupta SJ; Chaudhary A; Garg VK
    Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics.
    Agrawal N; Dhakrey P; Pathak S
    Chem Biol Drug Des; 2023 Oct; 102(4):921-938. PubMed ID: 37232059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
    Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
    Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs.
    Coronell-Tovar A; Pardo JP; Rodríguez-Romero A; Sosa-Peinado A; Vásquez-Bochm L; Cano-Sánchez P; Álvarez-Añorve LI; González-Andrade M
    FEBS Lett; 2024 Aug; 598(15):1811-1838. PubMed ID: 38724486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
    Prabhakar PK; Sivakumar PM
    Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
    Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
    Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
    Teimouri M; Hosseini H; ArabSadeghabadi Z; Babaei-Khorzoughi R; Gorgani-Firuzjaee S; Meshkani R
    J Physiol Biochem; 2022 May; 78(2):307-322. PubMed ID: 34988903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in protein tyrosine phosphatase 1B inhibitors.
    Taylor SD; Hill B
    Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
    Zhang ZY; Lee SY
    Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
    Goldstein BJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors.
    Ezzat SM; Bishbishy MHE; Habtemariam S; Salehi B; Sharifi-Rad M; Martins N; Sharifi-Rad J
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30558294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
    Popov D
    Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 - 2014).
    Tamrakar AK; Maurya CK; Rai AK
    Expert Opin Ther Pat; 2014 Oct; 24(10):1101-15. PubMed ID: 25120222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.